JVI Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
JVI Accepts, published online ahead of print on 27 February 2008
This Article
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JVI.02612-07v1
82/9/4227    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zhong, N.
Right arrow Articles by Xia, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zhong, N.
Right arrow Articles by Xia, B.

 Previous Article  |  Next Article 

J. Virol. doi:10.1128/JVI.02612-07
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

Without its N-Finger, SARS-CoV Main Protease can Form a Novel Dimer through its C-Terminal Domain

Nan Zhong, Shengnan Zhang, Peng Zou, Jiaxuan Chen, Xue Kang, Zhe Li, Chao Liang, Changwen Jin, and Bin Xia*

From Beijing Nuclear Magnetic Resonance Center, College of Chemistry and Molecular Engineering, and College of Life Science, Peking University, Beijing 100871, China

* To whom correspondence should be addressed. Email: binxia{at}pku.edu.cn.


   Abstract

The main protease (Mpro) of severe acute respiratory syndrome coronavirus (SARS-CoV) plays an essential role in the extensive proteolytic processing of the viral polyproteins (pp1a and pp1ab), and it is an important target for anti-SARS drug development. It was found that SARS-CoV Mpro exists in solution as equilibrium of both monomeric and dimeric forms, and the dimeric form is the enzymatically active form. However, the mechanism of SARS-CoV Mpro dimerization, especially the roles of its N-terminal seven residues (N-finger) and its unique C-terminal domain in the dimerization, remain unclear. Here, we report that SARS-CoV Mpro C-terminal domain alone (residues 187-306, Mpro-C) is produced in E. coli in both monomeric and dimeric forms, and no exchange could be observed between them at room temperature. The Mpro-C dimer has a novel dimerization interface. Meanwhile, the N-finger deletion mutant of SARS-CoV Mpro also exists as both stable monomer and stable dimer, and the dimer is formed through the same C-terminal domain interaction as that in the Mpro-C dimer. However, no C-terminal domain mediated dimerization form can be detected for the wild-type SARS-CoV Mpro. Our study results help to clarify previously published controversial claims about the role of N-finger in SARS-CoV Mpro dimerization. Apparently, without the N-finger, SARS-CoV Mpro can no longer retain the active dimer structure; instead it can form a new-type of dimer which is inactive. Therefore, the N-finger of SARS-CoV Mpro is not only critical for its dimerization, but also essential for the enzyme to form the enzymatically active dimer.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. Mol. Cell. Biol. Microbiol. Mol. Biol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.